XML 35 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity
 6 Months Ended
Oct. 03, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders' Equity
Dividends
On November 6, 2025, we announced that our Board of Directors declared a cash dividend of $0.125 per share of common stock to be paid in December 2025. All shares of common stock issued and outstanding and all RSUs and performance-based restricted stock units (PRUs) as of the record date will be entitled to the dividend and dividend equivalent rights, respectively, which will be paid out if and when the underlying shares are released. However, the 4 million unvested RSUs assumed in connection with the acquisition of Avast and the 4 million assumed RSUs under the MoneyLion Plan will not be entitled to dividend equivalent rights (DERs). See Note 15 for further information about these equity awards. Any future dividends and DERs will be subject to the approval of our Board of Directors.
Contingent value rights
In connection with the acquisition of MoneyLion, we issued 12 million equity-classified CVRs to MoneyLion shareholders and optionholders. The CVRs entitle holders to receive a contingent payment of $23.00 per CVR, payable in shares of Gen’s common stock, if our average volume-weighted average share price equals or exceeds $37.50 over any 30 consecutive trading days from December 10, 2024 until 24 months after close. The CVRs were recorded as a component of additional paid-in capital at a fair value of approximately $73 million as of the acquisition date, based on a Monte-Carlo simulation valuation model. As of October 3, 2025, there were 12 million CVRs outstanding, subject to the achievement of specified stock price conditions. Refer to Note 4 for additional information regarding the CVRs and our acquisition of MoneyLion.
Stock repurchase program
Under our stock repurchase program, we may purchase shares of our outstanding common stock on the open market and through accelerated stock repurchase transactions. As of October 3, 2025, we had $2,594 million remaining under the authorization to be completed in future periods.
The following table summarizes activity related to our stock repurchase program during six months ended October 3, 2025 and September 27, 2024:
 
Six Months Ended
(In millions, except per share amounts)
October 3, 2025September 27, 2024
Number of shares repurchased5 11 
Average price per share$27.86 $24.65 
Aggregate purchase price$134 $272 
We did not have any stock repurchases during the three months ended October 3, 2025 and September 27, 2024.
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income (loss), net of taxes, consisted of foreign currency translation adjustments and unrealized gain (loss) on derivative instruments:
(In millions)Foreign Currency
Translation Adjustments		Unrealized Gain (Loss) On
Derivative Instruments		Total
Balance as of March 28, 2025$(36)$3 $(33)
Other comprehensive income (loss), net of taxes39 (2)37 
Balance as of October 3, 2025$3 $1 $4